HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 44 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $48,000 | +9.1% | 146,430 | +138.6% | 0.00% | – |
| Q2 2020 | $44,000 | +175.0% | 61,364 | +160.5% | 0.00% | – |
| Q3 2019 | $16,000 | -75.0% | 23,560 | -38.8% | 0.00% | – |
| Q2 2019 | $64,000 | +68.4% | 38,525 | +153.9% | 0.00% | – |
| Q1 2019 | $38,000 | -82.4% | 15,174 | -82.1% | 0.00% | – |
| Q4 2018 | $216,000 | +315.4% | 84,838 | +436.3% | 0.00% | – |
| Q2 2018 | $52,000 | -46.4% | 15,818 | -41.0% | 0.00% | – |
| Q1 2018 | $97,000 | +288.0% | 26,792 | +150.7% | 0.00% | – |
| Q3 2016 | $25,000 | – | 10,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
| Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
| Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
| HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
| Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
| Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
| WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
| Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
| Virtu Financial LLC | 12,049 | $4,000 | 0.00% |